Similar Search Results

Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries

Oppermann, Julia - 2008

Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …

Persistent link: https://www.econbiz.de/10009475357

An Empirical Assessment of House Price Adjustments on Aggregate Consumption

Thomson, Matt; Tang, Kam Ki - 2004

This study measures the effect of changes in net housing and financial wealth on household consumption. The link between consumption, income and net wealth is measured within a Dynamic Ordinary Least Squares and a Dynamic Generalised Least Squares framework for the period Q2:1988-Q1:2003. It is...

Persistent link: https://www.econbiz.de/10009448066

Wealth Effects of the Gramm-Leach-Bliley Act on Financial Services Industry

Mamun, Abdullah - 2003

Gramm-Leach-Bliley Act (GLBA) was signed into law on November 12, 1999.This act is regarded as the most influential deregulation for the U.S. financial servicesindustry in the past one-century. The purpose of this study is to determine and analyze thewealth effects of the GLBA on U.S. and...

Persistent link: https://www.econbiz.de/10009468600

Wealth Effects of the Gramm-Leach-Bliley Act on Financial Services Industry

Mamun, Abdullah - 2003

Gramm-Leach-Bliley Act (GLBA) was signed into law on November 12, 1999. This act is regarded as the most influential deregulation for the U.S. financial services industry in the past one-century. The purpose of this study is to determine and analyze the wealth effects of the GLBA on U.S. and...

Persistent link: https://www.econbiz.de/10009451121

Wealth effect of auditor switch during crisis and non-crisis period : the Malaysian experience

Ismail, Shahazaz; Nasir, Annuar M. D.; Ali Ahmed, Huson … - 2006

This study examines the auditor switch effect on share prices among listed companies in Malaysia, mainly the Second Board companies during economic crisis and the economic growth period. Data on companies listed on the KLSE that reported switching of auditors were gathered from the respective...

Persistent link: https://www.econbiz.de/10009484061

Assessing Quality Improvement Infrastructure in the Formation of Accountable Care Organizations: A Regional Policy Analysis for the Pharmaceutical Industry

Carr-Whealy, Nathan - 2011

Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...

Persistent link: https://www.econbiz.de/10009434765

OS NOVOS RUMOS DA ESTRATÉGIA DE MARKETING NO MERCADO FARMACÊUTICO

Correa, Gisleine Fregoneze; Oliveira, Luciel Henrique de - 2008

The pharmaceutical industry invests its sales force in contacts with doctors, making visits and publicizing its drugs, in orderfor them to prescribe these products to their patients. This work discusses the structure of the pharmaceutical market and howmarketing strategies are used by...

Persistent link: https://www.econbiz.de/10009446936

Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act

Grabowski, Henry; Vernon, John - 1992

IN 1984, Congress enacted a new law that greatly affected the economicsof the pharmaceutical industry in the United States. It has been characterizedas the most important legislation affecting competition in the pharmaceuticalindustry since the 1962 Kefauver-Harris Amendments to theFood and Drug...

Persistent link: https://www.econbiz.de/10009475542

Substitution laws and innovation in the pharmaceutical industry.

Grabowski, Henry; Vernon, John - 1979

innovation process through the distribution and marketing of pharmaceuticals. In contrast to other products, drugs can be …

Persistent link: https://www.econbiz.de/10009475544

Precedence of institutions over research environment in determining growth in Uttar Pradesh in India

Panda, Hrushikesh - 2008

has a conducive research environment for development ofdrugs and pharmaceuticals industry with many central government … organizations carryingout research related to the industry. Drugs and pharmaceuticals is a research intensiveindustry. In a … Pradeshshould be in a position to attract investment into the drugs and pharmaceuticals industry.However, it is observed that there …

Persistent link: https://www.econbiz.de/10009475795